20
Participants
Start Date
September 16, 2019
Primary Completion Date
December 23, 2019
Study Completion Date
December 23, 2019
CBD 800 mg p.o
cannabidiol solution 100 mg/ml 8 ml in single-dose containers for per os administration. After a washout period of at least two weeks, the treatment group will be receiving a single-dose of the placebo solution 8 ml as a second intervention.
Placebo p.o
single dose of oral placebo solution 8 ml matched to the IMP. After a washout period of at least two weeks, the control intervention group will be receiving the cannabidiol solution 100 mg/ml 8 ml as a second intervention.
Department of Anaesthesiology, University Hospital of Basel (USB), Basel
University Hospital, Basel, Switzerland
OTHER